These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19225229)

  • 1. [Long-term remission of a nasal NK/T-cell lymphoma patient with massive involvement of the orbita and liver dysfunction].
    Monma F; Ueno S; Yamaguchi M; Tawara I; Miyazaki K; Nishii K; Nakase K; Katayama N
    Rinsho Ketsueki; 2009 Jan; 50(1):44-8. PubMed ID: 19225229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
    Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
    J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
    Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
    J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.
    Huang MJ; Jiang Y; Liu WP; Li ZP; Li M; Zhou L; Xu Y; Yu CH; Li Q; Peng F; Liu JY; Luo F; Lu Y
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):166-74. PubMed ID: 17919841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
    Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temporary effective treatment with L-asparaginase for a patient with refractory nasal NK/T-cell lymphoma].
    Sakamoto E; Yamane T; Nakane T; Takeoka Y; Hirose A; Hagihara K; Nakamae H; Ohta K; Hirayama M; Ikura Y; Ohsawa M; Sawada T; Kitoh T; Hino M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1993-6. PubMed ID: 16282743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
    Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
    J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers.
    Huang L; Yuan B; Wu H; Chu H; Liu Y; Wu S; Li H; Lu H; Chen H
    Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):152-158. PubMed ID: 28215935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage treatment improved survival of patients with relapsed extranodal natural killer/t-cell lymphoma, nasal type.
    Zhang XX; Xie CH; Xu Y; Deng D; Zhao YH; Zou BW; Zhou L; Li M; Wang J; Liu WP; Huang MJ
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):747-52. PubMed ID: 19304409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy for limited-stage extranodal natural killer/t-cell lymphoma, nasal type.
    Shimada K; Suzuki R
    J Clin Oncol; 2010 May; 28(14):e229; author reply e230. PubMed ID: 20351319
    [No Abstract]   [Full Text] [Related]  

  • 12. Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
    Hildyard C; Sheikh S; Eyre T; Collins G
    Br J Haematol; 2013 Dec; 163(5):550. PubMed ID: 24033120
    [No Abstract]   [Full Text] [Related]  

  • 13. L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.
    Yong W; Zheng W; Zhu J; Zhang Y; Wang X; Xie Y; Lin N; Xu B; Lu A; Li J
    Ann Hematol; 2009 Jul; 88(7):647-52. PubMed ID: 19107482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56-negative extranodal nasal type NK/T-cell lymphoma.
    Miles RR; Afify Z; Yaish H; Perkins SL
    Pediatr Blood Cancer; 2010 Jul; 55(1):186-9. PubMed ID: 20486184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
    Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
    Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.
    Koizumi K; Fujimoto K; Haseyama Y; Endo T; Nishio M; Yokota K; Itoh T; Sawada K; Koike T
    Eur J Haematol; 2004 Feb; 72(2):140-4. PubMed ID: 14962252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy].
    Tamai Y; Imataki O; Abe Y; Hagiwara S; Ito I; Asakura H; Harada H; Kamata M; Nishimura T; Kawakami K
    Gan To Kagaku Ryoho; 2006 May; 33(5):687-90. PubMed ID: 16685174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal sinonasal natural killer/T-cell lymphoma presenting as chronic sinusitis and necrotic wound infection.
    Karaman E; Yilmaz M; Alimoglu Y; Edizer DT; Isildak H; Ozek H
    J Craniofac Surg; 2009 Nov; 20(6):2095-6. PubMed ID: 19881363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma.
    Li YX; Wang H; Jin J; Wang WH; Liu QF; Song YW; Wang ZY; Qi SN; Wang SL; Liu YP; Liu XF; Yu ZH
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1809-15. PubMed ID: 21470789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
    Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
    Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.